Recent BTAI Stock Price | BTAI Stock Predictions | |
$2.71 | +170.48% |
$7.33 |
Recent BTAI Analyst Ratings Breakdown, Making BTAI Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 3 | 3 | 3 | 3 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 3 | 4 | 4 | 3 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 2.0 | 2.14 | 2.14 | 2.0 |
For the BTAI stock predictions from the analysts covering BioXcel Therapeutics Inc, we have collected all of the individual BTAI stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 6 different analysts covering BTAI (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since BTAI stock predictions may vary widely, another useful metric to consider is the median BTAI stock prediction, which represents the price at which half of the analysts
made BTAI stock predictions that were higher and half made BTAI stock predictions that were lower. This makes for a different take on the BTAI stock predictions out there, as compared to average or mean.
And that median across all the individual BTAI stock predictions was: $7.0 as of 2024-04-25.
The very highest of the BTAI stock predictions for one year price target was $12.0, while the very lowest of the BTAI stock predictions in the analyst group was
$4.0 (with a standard deviation of $3.204). Get the latest Zacks research report on BTAI — FREE
Find out: BTAI next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
ZION Stock Predictions
QIWI Stock Predictions
NAT Stock Predictions
WMB Stock Predictions
NSC Stock Predictions
KN Stock Predictions
AQUA Stock Predictions
GES Stock Predictions
NUAN Stock Predictions
|
|
Buy (3.00 out of 4) 37th percentile
(ranked lower than approx. 63% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |